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Abstract
Background: Burkina Faso introduced the Integrated Management of Childhood Illnesses (IMCI) strategy in 2003.
However, an evaluation conducted in 2013 found that only 28 % of children were assessed for three danger signs
as recommended by IMCI, and only 15 % of children were correctly classified. About 30 % of children were
correctly prescribed with an antibiotic for suspected pneumonia or oral rehydration salts (ORS) for diarrhoea, and
40 % were correctly referred. Recent advances in information and communication technologies (ICT) and use of
electronic clinical protocols hold the potential to transform healthcare delivery in low-income countries. However,
no evidence is available on the effect of ICT on adherence to IMCI. This paper describes the research protocol of a
mixed methods study that aims to measure the effect of the Integrated electronic Diagnosis Approach innovation
(an electronic IMCI protocol provided to nurses) in two regions of Burkina Faso.
Methods/design: The study combines a stepped-wedge trial, a realistic evaluation and an economic study in order
to capture the effect of the innovation after its introduction on the level of adherence, cost and acceptability.
Discussion: The main challenge is to interconnect the three substudies. In integrating outcome, process and cost
data, we focus on three key questions: (i) How does the effectiveness and the cost of the intervention vary by type
of health worker and type of health centre? (ii) What is the impact of changes in the content, coverage and quality
of the IeDA intervention on adherence and cost-effectiveness? (iii) What mechanisms of change (including costs)
might explain the relationship between the IeDA intervention and adherence?
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Background
Despite a large reduction in under-5 child mortality
(from 180 per 1000 live births in 1990 to 83 per 1000
live births in 2015), sub-Saharan Africa failed to reach
the Millennium Development Goal 4 target of 60
deaths per 1000 live births [1]. In 1999, the World
Health Organization (WHO) developed the Integrated
Management of Childhood Illness (IMCI) strategy [2].
This strategy provides an algorithm to guide health
workers through a systematic clinical assessment of
sick children with the aim of improving the diagnos-
tic classification and the treatment of these children
[3–5] and hence reducing mortality [4, 6].
However, effective implementation of IMCI is often
constrained by poor adherence to the guidelines [7–9].
Previous studies have reported that adherence to the
guidelines decreases over time due to inadequate initial
training, shortage of staff and insufficient supervision
[10, 11]. Takada et al. [12] have noted that healthcare
workers typically find the IMCI chart booklet burden-
some and try to work from memory, resulting in a de-
crease in quality of care. In addition, healthcare workers
may omit sections resulting in incomplete assessments
[4, 13]. Chaudhary [10] demonstrated that the adherence
of health workers improved with supervision. However,
regular supervision of health workers after training is
often lacking [8, 13], partly due to the lack of resources.
Burkina Faso introduced the IMCI strategy in 2003.
However, an evaluation conducted in 2013 found that
only 22 % of nurses working in primary care facilities
had been trained in IMCI [14]. Only 28 % of children
were assessed for three danger signs as recommended
by IMCI, and only 15 % of children were correctly
classified [14]. About 30 % of children were correctly
prescribed with an antibiotic for suspected pneumonia
or oral rehydration salts (ORS) for diarrhoea, and
40 % were correctly referred [14].
Recent advances in information and communication
technologies (ICT) holds the potential to transform
healthcare delivery in low-income countries [15–17].
However, no evidence is available on the effect of
ICT on adherence to IMCI. Small-scale studies con-
ducted in Tanzania found ICT to be well accepted by
healthcare workers during IMCI consultations [7, 16].
However, the experience with using such technology
on a large scale is limited.
In 2010, Terre des Hommes (TdH), a Swiss non-
governmental organisation, together with the Ministry of
Health (MoH), launched the Integrated electronic
Diagnosis Approach (IeDA) intervention with the object-
ive of improving adherence to IMCI guidelines in public
primary health centres in two regions of Burkina Faso.
In this paper, we present the design of a mixed methods
evaluation of this intervention.
Burkina Faso is composed of 13 regions and 63
health districts. The public health system is charac-
terised by a three-tier service structure: (i) at the first
level are the districts with 1535 health centres
(Centre de Santé et de Promotion Sociale (CSPS))
and the 104 district hospitals (Centre Médical avec
Antenne Chirurgicale (CMA)), (ii) at the next level
are the nine regional hospitals (Centre Hospitalier
Régional (CHR)), and (iii) finally, the third level is
comprised of the three national teaching hospitals
(Centre Hospitalier Universitaire (CHU)) [18].
The IMCI approach was implemented only at the
first level of the pyramid, i.e. in health centres. These
facilities deliver a minimum package of services de-
fined by the Ministry of Health comprising both
preventive (e.g. vaccinations, antenatal care, health
education, and promotion of proper nutrition, hygiene
and safe water) and curative measures (e.g. treatment
of common illnesses, minor surgery, supply of essen-
tial medicine, maternal and child consultations). CSPSs
are governed by a management committee (Comite
de gestion) composed of members of the community.
The district health management team is in charge of
supervising CSPSs and analysing routine data col-
lected in them [19].
The Electronic Register of Consultations and the IeDA
intervention
The ‘electronic register of consultations’ or ‘Registre
Electronique de Consultations’ (REC) in French was de-
signed in 2010 by TdH [20]. The REC software, based
on the CommCare software language, is installed on the
open access CommCare platform developed by Dimagi
[21]. The REC guides health workers through the IMCI
algorithm. By doing so, it aims to improve adherence of
nurses to the clinical protocol and to provide the local
health district and the MoH with routine data on the
management of childhood illnesses. The first versions of
the REC were piloted in 2011 and 2012 in 52 primary
health facilities located in two districts in the Nord
region and perceived by 90 % of users (nurses) as being
a supportive tool during consultations [22]. An add-
itional pilot district, Yako, was added in the Boucle du
Mouhoun region in 2014 and 2015. Following the pilot
phase, the MoH requested TdH to expand the imple-
mentation of the REC to the remaining health districts
of both regions.
In order to do so, TdH launched in 2014 the IeDA
intervention, which includes the following five compo-
nents, delivered at district and health centre levels:
 Development and implementation of the improved
versions of the REC in all primary facilities of the
two regions (district level).
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 Provision, with the Ministry of Health, of a 7-day
training course on IMCI guidelines including 2 days
on the use of the REC to all primary health workers
working in each district to be covered (district level).
 Development of a quality assurance mechanism
through which each district and health centre
is encouraged to find appropriate solutions in
response to their local needs (district and health
centre levels).
 Supervise every month every health centre
benefiting from the intervention and support health
district authorities in their annual supervision of
health centres (health centre level).
 Development of a health information system based
on the data collected through the REC and fed back
to the district managers and heads of health centres
(district and health centre levels).
Methods/design
The evaluation methods
The IeDA intervention is being evaluated using a mixed
methods study design composed of the following three
interlinked studies (see Fig. 1):
1. A stepped-wedge trial to evaluate the effect of IeDA
on the adherence to IMCI guidelines in primary
health facilities
2. A cost-effectiveness analysis (CEA) to assess the
value for money of the delivery of IeDA
3. A realistic evaluation to understand the
implementation process, the mechanisms by which
the IeDA intervention leads to change and to
identify factors that may affect these mechanisms at
the health centre and community levels
These three studies are taking place in a total of eight
health districts across the Nord and Boucle du Mouhoun
regions, with the three districts where TdH piloted the
REC excluded from the evaluation.
The stepped-wedge trial
Stepped-wedge trials are a type of cluster randomised
trial in which clusters receive the intervention at differ-
ent time points and the order in which they receive the
intervention is randomised [23, 24]. Some aspects of the
intervention can only be delivered at the district level,
and other aspects are most conveniently delivered by
district and so, we are using a cluster randomised trial
with districts as clusters. The two regions have 11 dis-
tricts, three of which received the pilot intervention and
so, the evaluation will be restricted to the eight
remaining districts. The implementing agencies (the
MoH and TdH) need to roll out the intervention in a
phased implementation approach for logistical reasons,
with the intervention introduced into one additional dis-
trict every 4 months. Hence, we are using a stepped-
wedge design, with the order in which the eight districts
receive the intervention determined by computer-based,
restricted randomisation (Fig. 2).
The intention was that the intervention would eventu-
ally be delivered to all primary health centres in all eight
districts. Also, during the period preceding the interven-
tion (i.e. in year 1 step 1), a first round of data collection
would be conducted in the eight districts to provide pre-
intervention measurements in all districts.
The aim of the trial is to determine whether the IeDA
intervention increases adherence to the IMCI algorithm
and hence improves classification, referral, prescription
and counselling during under-5 child consultations in
IeDA Implementation:
What is delivered and how
delivery is achieved
Mechanisms of change:
Participant responses to, 
and interactions with, 
the IeDA intervention
Outcomes:
Adherence to IMCI guidelines
Cost-Effectiveness
STEPPED WEDGE TRIAL 
COST-EFFECTIVENESS ANALYSIS
REALISTIC EVALUATION
time
Fig. 1 Evaluation mixed methods study framework
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health centres. This will be determined by observation
of child consultations followed by a repeat consultation
by study staff in selected CSPS.
There are two co-primary outcomes, one task-based
and one results-based, both measured at individual level
using direct observation [25–27]:
1. Degree of adherence to IMCI guidelines, measured
as a quantitative variable
2. Correct disease classification and prescription,
measured as a binary variable
The secondary outcomes related to under-5 children
consultations are as follows:
1. Correct identification of danger signs
2. Correct classification of children
3. Prescription of the correct medicine
4. Correct referral or hospitalisation
5. Correct counselling delivered to child carer
Selection of primary health centres
The evaluation is being conducted in ten randomly
chosen primary health centres per health district. The
list of CSPSs selected for the evaluation has not been
communicated to the implementing agency to reduce
the likelihood that they target these health centres for
more intensive support. Ten CSPS per district was
chosen to give sufficient contextual variation, while
minimising logistical difficulties and ensuring that some
CSPS in each district were not selected to allow for se-
lection concealment. Only primary health centres with
staff trained in IMCI were considered for selection, and
all hospitals were excluded. The intervention effect may
vary by health centre workload, and so, the selection was
stratified on the 2013 annual under-5 consultations
caseload, as provided by the MoH. For the 337
CSPSs with staff trained in IMCI in the eight dis-
tricts under evaluation, the annual caseload was
transformed into a daily rate by dividing it by
261 days (i.e. the number of working days). Out of
the 337 CSPSs, 13 were excluded, either because of
missing caseload data (six CSPS) or because of a
zero recorded caseload (seven CSPS). Out of the
remaining 324 CSPSs, a further 54 CSPSs were ex-
cluded because they had caseloads of less than three
cases per working day, which would have limited the
number of consultations that could be observed in
these facilities. Although these 54 CSPSs represented
17 % of the remaining 324 CSPSs, they only repre-
sent 4 % of the total caseload in 2013. In each dis-
trict, five CSPSs were then randomly selected among
those with fewer than seven cases per working day
and five CSPSs were randomly selected among those
with seven cases or more per working day (on aver-
age). Seven cases were chosen for the cutoff as this
ensured there were at least nine CSPSs in each of
the two strata in each district. Data will be collected
in the same ten CSPSs per district during each step
of the stepped-wedge trial during a 1- to 2-day visit
(see the ‘Data collection’ section below).
Sample size calculation Using the method described by
Hussey and Hughes [28] and assuming that:
1. Ten health centres in eight districts will be visited
every step.
2. A harmonic mean of ten children will present at each
health facility over the course of a 1- to 2-day visit.
3. Sampling ten children per facility per round carries a
design effect of 2.
4. The coefficient of variation between clusters is 0.3.
Year 1 Year 2 Year 3 Year 4
Districts T1 T2 T3 T4 T5 T6 T7 T8 T9
#8
#7
#6
#5
#4
#3
#2
#1
Fig. 2 The sequence of districts receiving the intervention after each period of 4 months during the stepped-wedge trial
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Then, there is 90 % power to detect an increase in the
correct diagnosis and treatment from 25 to 33 %. If there
is only a harmonic mean of four children at each health
centre, there will be 98 % power to show an increase
from 25 to 40 %.
Randomisation There are eight districts (five in Boucle
du Mouhoun region and three in the Nord region) in
the stepped-wedge trial. Restricted randomisation was
used to allocate one cluster (i.e. one district) to receive
the intervention in each of the eight time periods [29].
The order in which the eight districts receive the inter-
vention was subject to three constraints that address
the following circumstances in which the trial was
being performed:
1. An international organisation will be implementing a
performance-based financing (PBF) intervention in
four of the eight districts during the study, which
may influence the performance of the health
workers. In addition, two of the eight districts will
act as ‘control’ clusters for their study, and so, it
would be better if the IeDA intervention does not
start in both these clusters before starting in any
other cluster.
2. An international donor is prepared to provide
support for two of the five districts in the Boucle
du Mouhoun region, but they needed to start
doing this soon.
3. There needs to be some balance in the
randomisation order across the two regions.
Hence, the following restrictions were applied:
1. There must be one PBF intervention district and one
PBF non-intervention district (either a control dis-
trict or one excluded from the study) in each pair of
randomised districts, i.e. in the first and second dis-
tricts to receive the intervention, the third and
fourth districts, the fifth and sixth districts and the
seventh and eight districts. The difference in the
average order of the PBF intervention districts and
the non-intervention districts must be less than one.
The first three districts must not include both PBF
control districts.
2. At least one of the first two districts must be in the
Boucle du Mouhoun region.
3. At least one of the first three districts and at least
one of the last three districts must be from the Nord
region.
Applying these criteria to the 40,320 possible randomi-
sations resulted in 4224 acceptable allocations. For these
4224, no district was in a given position in the random
order for less than 6.9 %, or more than 17.0 %, of accept-
able allocations (292 and 720 acceptable allocations, re-
spectively). If two districts were always next to each
other in the order, then they should be treated as one
district in the analysis, but among the 4224 acceptable
allocations, the least and most common pairing of dis-
tricts occurred in 6.8 and 42.8 % of acceptable alloca-
tions, respectively. We therefore judged that the
restricted randomisation had not resulted in an overly
constrained set of possible allocations and one of the
4224 acceptable allocations was chosen at random. This
was done in Stata v13, by sorting the 4224 acceptable al-
locations on a variable containing random numbers gen-
erated by the ‘uniform()’ command and then choosing
the allocation with the smallest random number; this
was done by a statistical co-investigator (JL). This alloca-
tion will be communicated to the TdH and the MoH
gradually, so they only know the next two districts to re-
ceive the intervention.
Data collection As outcome measures, the trial is asses-
sing the adherence to IMCI guidelines and the correct-
ness of the illness classification, prescription, referral (if
necessary) and counselling.
Each selected CSPS is visited for 1 or 2 days at each
‘step’ of the trial by a team of two staff from the evalu-
ation team. One member of staff observes all under-5
children consultations performed by the local health
workers while the other reassesses children after their
consultation with the local health worker. Our teams no-
tify the head of the health centre the afternoon of the
day before our visit.
The first member of the evaluation team records infor-
mation regarding each consultation in a detailed obser-
vation form. Three observation forms were designed,
one per age category defined by the IMCI guidelines (i.e.
0–7 days, 7 days–2 months, 2 months–5 years) and pre-
tested to include all questions or tasks that a healthcare
worker should perform when following the IMCI guide-
lines. Each observation form is divided into sections cor-
responding to the different sections in the IMCI
protocol for each age category. For instance, the obser-
vation form to observe consultations of children from
2 months to 5 years old includes sections for the assess-
ment of danger signs: cough or fast/difficult breathing,
diarrhoea, fever, ear problems, anaemia, nutritional sta-
tus, HIV, immunisation and vitamin A uptake, referral,
treatment and counselling. Observations are passive, and
the observer never intervenes during the consultation.
Information recorded in the observation form also in-
cludes whether the nurse referred to the IMCI chart
booklet during the consultation or used the REC (if the
district benefited from the intervention), as would be ex-
pected if IMCI was being implemented correctly. If the
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health centre has more than one nurse conducting child
consultations, the observer follows the first child who is
called for consultation.
Following observation of a consultation, the second
member of the evaluation team, expert in IMCI, re-
assesses the child independently using the REC to provide
a ‘gold standard’ against which to compare local health
workers’ classifications and treatment decisions. In case of
discrepancies between the health worker and the IMCI ex-
pert, the final management decision is determined follow-
ing discussions between the two of them.
In addition to observations and repeat assessments, a
questionnaire, based on the WHO Service Availability
and Readiness Assessment questionnaire [30], was devel-
oped to document the context in which the trial is con-
ducted. This questionnaire is completed at each visit to
a CSPS and captures information on the resources avail-
able for management of childhood illnesses according to
the IMCI guidelines.
Two evaluation teams (each comprised of two members)
were recruited for data collection. They had all previously
been trained in IMCI by the Ministry of Health and had at
least 5 years of experience of IMCI in their health centre.
In addition, they underwent 2 weeks of training on the
study methods, provided by the investigators.
Analysis The stepped-wedge design can be analysed in
different ways [31]. In the primary analysis, each step
will be analysed using methods appropriate for a parallel
cluster randomised trial, using district-level summaries
of the outcome to calculate a difference measure. These
difference measures will be combined across steps using
inverse variance weighting. Hypothesis testing will be
based on bootstrapping or a permutation test.
In the secondary analysis, the method described by
Hussey and Hughes [28] will be used. As the outcome is
likely to be relatively common, the risk difference will be
modelled using generalised estimating equations at the
level of the child consultation, with fixed effects for
intervention versus control phase, time step and district
and clustering at the level of the health centre.
Potential imbalances at the level of the child and the
health centre between intervention and control phases
will be investigated and any imbalances will be adjusted
for. A priori, adjustment will also be made for district-
level summaries of the outcome at baseline.
A detailed statistical analysis plan will be prepared be-
fore the end of data collection.
Cost-effectiveness analysis
The aim of this sub-study is to estimate the value for
money of implementing IeDA compared to current prac-
tice (implementing standard IMCI, based on the paper-
based IMCI protocol) in the diagnosis of under-5 chil-
dren in primary healthcare centres in Burkina Faso. The
CEA, embedded within the IeDA stepped-wedge trial,
will estimate both the cost per consultation and the in-
cremental cost per child correctly managed associated
with delivering IeDA compared to delivering standard
IMCI. The perspective for the CEA is that of the health-
care provider, i.e. the MoH. For both standard IMCI and
IeDA, costing will be undertaken using a micro-costing
approach [32]. For each of the two interventions, the
main components of the cost per consultation are as fol-
lows: (i) programme costs, i.e. costs associated with the
implementation of the intervention that are incurred at
the administrative level outside the point of delivery of
healthcare, and (ii) patient costs or costs associated with
the implementation of the intervention which are in-
curred at the point of delivery of healthcare [33]. To ob-
tain an adequate estimate of the cost per consultation
for each of the two interventions, programme costs will
be allocated to patient costs using established cost allo-
cation procedures [32].
The cost per consultation of IeDA and standard IMCI
will be estimated using an observational before-and-after
study design in the district of Ouahigouya, one of the
districts included in the stepped-wedge trial. In this
district, the costs per consultation of standard IMCI will
be estimated during the 6-month period prior to IeDA
implementation. The cost per consultation for IeDA will
be estimated during the 6-month period after IeDA
implementation.
For both arms, all resource consumption affecting
programme costs at health centre and district level will
be measured prospectively using surveys. This data will
be supplemented with data from health centre and dis-
trict accounts. All resource consumption affecting
programme costs at national level will be measured
retrospectively via interviews with agents who have par-
ticipated in the implementation of both interventions
(mostly MoH officers and, in the case of IeDA, also TdH
coordinators). Resource consumption affecting patient
costs will be measured using data recorded in the REC
for every consultation in the ten Ouahigouya health cen-
tres selected for the stepped-wedge trial which is moni-
tored in the period between 6 months before and
6 months after IeDA implementation. For each of the
two interventions, the number of consultations moni-
tored in the Ouahigouya health centres during this
period is scheduled to be 80. Data collected in the REC
for each patient consultation includes (i) duration of the
consultation and (ii) medications prescribed in the con-
sultation. An additional form will be added to the REC
to measure consumables used during each patient
consultation. To minimise bias in the measurement of
resource consumption due to seasonal effects on
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healthcare delivery, data on resource consumption from
all the consultations monitored in the stepped-wedge
trial (whether standard IMCI or IeDA) 3 months before
and 3 months after IeDA implementation in Ouahigouya
will be used in the estimation of patient costs. Once re-
source consumption is measured, costs will be calculated
using unit prices for each resource consumed. Depend-
ing on the specific type of resource, unit prices will be
obtained from MoH databases, MoH price lists or sup-
plier catalogues.
Regression analysis will be used to estimate the mean
difference in costs per consultation between IeDA and
standard IMCI. Cost-effectiveness modelling will be used
to assess the incremental cost-effectiveness of IeDA ver-
sus standard IMCI.
Realist evaluation
For Pawson and Tilley [34], issues of context and mechan-
ism are crucial elements to consider in any realist evalu-
ation as they help to explain ‘what works, for whom and
in what circumstances’. For these authors, ‘what works’ is
not of itself a helpful question as: ‘programs work (have
successful “outcomes”) only insofar as they introduce the
appropriate ideas and opportunities (“mechanisms”) to
groups in the appropriate social and cultural conditions
(“contexts”)’. Focusing on the realist dimensions enables
us to examine the particular significance of ‘mechanism’
and ‘context’ more closely.
We will use longitudinal research, using a case study
design [35], to enable us to understand the impact of
key features or mechanisms for IeDA users and the con-
text in which adherence to protocols is achieved (or not)
over time.
In the case studies, the task of the research team will
be to identify different context and mechanism configu-
rations. These case studies will be purposively selected
in relation to the performance of the health centre (in
terms of adherence to the protocol) and the capacity of
health centre staff to reflect on their experience. In-
formed by data from the stepped-wedge trial (high-per-
forming and low-performing health centres), new cases
identified from the list of health centres randomly se-
lected in the trial will be added to our purposive sample.
Four intervention health centres with high performance
(positive cases) and four intervention health centres (de-
viant cases) with low performance will be selected.
Given the broad scope of the study and a desire to
capture how IeDA works in situ, we will use a combin-
ation of methods:
1. Non-participant and participant observation of
nursing and multi-disciplinary activities related to
the use of IeDA (e.g. supervision from district man-
agers, relation with pharmacist)
2. Post-observation interviews guided by issues arising
from observations
3. Social network analysis to explore whether the
nature of relationships between the actors of the
health system will change [36, 37]
4. Key stakeholder interviews exploring views in
general about the use, influences on use and impact
of IeDA. We will record the interviews and code
and analyse them using the software NVivo
5. Interviews with patients about their experience of IeDA
6. Survey questionnaire administered to REC users to
understand their experience using the tool and
perceptions on the benefits or constraints of REC
7. Review of relevant documentation (e.g. reports,
statistics)
8. Field notes written during and after each visit
In the realist evaluation sub-study, the analysis will
consist of identifying patterns and variables in one case
study [38] through a ‘pattern matching’ process [39] and
verifying the presence of the same pattern in other case
studies where it was expected to obtain the same pat-
tern, what Yin called ‘theoretical replication’ [38, p. 116].
Cross comparisons will also be made with deviant cases
where other patterns are expected to be found for pre-
dicted reasons.
To enable comparisons, data analysed in the trial on
the level of adherence, resource availability and health
facility size and compared across areas and health cen-
tres will be used to identity well-performing heath cen-
tres and poorly performing health centres. This will
allow qualitative cross-case analysis taking into account
similarities and differences between health centres.
Discussion
Interconnected sub-studies
With the IeDA study, we aim for a holistic evaluation in
which outcome, process and cost data are integrated in
the analysis of the findings to maximise our capacity to
understand the effect of the introduction of a complex
intervention into a specific context.
In integrating outcome, process and cost data, we
focus on three key questions: (i) How does the effective-
ness and the cost of the intervention vary by type of
health worker and type of health centre? (ii) What is the
impact of changes in the content, coverage and quality
of the IeDA intervention on adherence and cost-
effectiveness? (iii) What mechanisms of change (includ-
ing costs) might explain the relationship between the
IeDA intervention and adherence?
To explore whether more intensive implementation of
the IeDA intervention can generate better adherence
outcomes, data collected on implementation parameters
(e.g. fidelity and dose) will be used to categorise and
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rank health centres. We will calculate the correlation be-
tween outcome and the fidelity and dose of the IeDA
intervention.
In addition, process and cost data will be integrated
into the trial analysis to identify new hypotheses on fac-
tors influencing the performance of health centres. Two
factors that may play an important role in performance
are (1) the characteristics of health workers (e.g. their
experience in IMCI, the time allocated to each consult-
ation) and (2) the characteristics of health centres (e.g.
team structure, leadership, resources available).
Ethics
The Ethics Committee of the Ministry of Health of
Burkina Faso and the Ethics Review Committee at the
London School of Hygiene & Tropical Medicine have
approved the trial. Risks and burdens to the patients and
the nurse as a consequence of the study are minimal.
Every nurse at the health centre level who will be
observed will be informed about the study and the pro-
cedures and written consent will be requested. Carers of
children will give written informed consent to provide
authorisation for one of the researchers to observe the
consultation conducted by the nurse and for the other
researcher to conduct a repeat consultation.
An information sheet in the local language will be read
to all participants (carers who accompany children,
nurses, MoH Officials, NGO and United Nations
Officers). Participants will be encouraged to ask ques-
tions about the research. If consent is given, they will
be asked to sign either their name or, if unable to do
so, provide their verbal assent and print their thumb
print, on the attached consent form.
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